We present a case of severe rigidity during emergence from general anaesthesia in a 64-year-old man who had suffered from Parkinson's disease for nine years. Controversy still exists over how to optimally manage these patients perioperatively. We successfully managed his Parkinsonism with administration of crushed Sinemet ® and amantadine via a nasogastric tube. This case report serves as a reminder of the importance that patients receive their anti-Parkinsonian medications perioperatively, and highlights the potential benefits of inserting a gastric tube to continue anti-Parkinson's medication dosing during prolonged surgery.
Parkinson's disease is a relatively common neurodegenerative disorder which affects approximately 3% of the population over 66 years of age and has a male preponderance 1 . Although the exact aetiology is unknown, increasing age is the most consistent associated factor. The neurodegenerative death of dopaminergic neurons in the pars compacta of the substantia nigra leads to the classic triad of rigidity, resting tremor and bradykinesia 2 .
It is known that these patients are at greater risk of perioperative complications 1, 3, 4 involving neurological, respiratory, cardiovascular, gastrointestinal and autonomic systems. What is less clear is how to optimally manage these patients under anaesthesia. To date, the anaesthetic literature on this topic emphasises ensuring anti-Parkinson's medications are not missed preoperatively while fasting, avoiding anti-dopaminergic medications, using opioids cautiously (all of which may exacerbate rigidity) and the potential benefits of regional anaesthesia/ analgesia (i.e. to minimise drug interactions and nausea, and to enable earlier resumption of oral intake and medication) 1,2 . In general, pharmacological agents used for general anaesthesia are thought to be safe 1, 2 .
While anaesthetists recognise the importance of avoiding missing doses of anti-Parkinson's medication, it is not known whether it is necessary to continue dosing during more prolonged surgery, how best this is achieved and how best to manage an exacerbation should it occur on awakening. We describe our approach to the management of severe Parkinson's rigidity in a patient during emergence from anaesthesia. The patient gave his consent for this publication.
CASE HISTORY
A 64-year-old man was scheduled for intramedullary nail fixation for a fractured humerus. He had been suffering from Parkinson's disease for nine years, and his long-term anti-Parkinson's treatment was levodopa 250 mg/carbidopa 25 mg (Sinemet ® , Merck Sharp and Dohme (Australia) Pty Ltd, Sydney, NSW) five times per day and amantadine (Novartis Pharmaceuticals Australia Pty Limited, Sydney, NSW) 100 mg twice a day. He described mild tremor and anxiety with missed doses. On the day of surgery, he took all his usual medications, including his midday dose of Sinemet one hour prior to surgery as requested.
On arrival in the operating room, he displayed no Parkinson's symptoms. Surgery was expected to take no more than two hours. Anaesthesia was induced with propofol 110 mg, fentanyl 100 µg, midazolam 1 mg and muscle relaxation was achieved with rocuronium 50 mg. Anaesthesia was maintained with desflurane at 1 minimum alveolar concentration in the beach-chair position. For analgesia, he received, in total, morphine 20 mg, paracetamol 1 g, parecoxib 40 mg, tramadol 100 mg and clonidine 60 µg (for tourniquet pain) during about six hours of operating
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There was concern that due to the unexpectedly prolonged surgery there was a high risk of rigidity on emergence. A neuromuscular transmission monitor (Datex-Ohmeda NMT ® module, GE Healthcare, Chalfont St. Giles, UK) device was applied prior to emergence and the train-of-four ratio was 0.9. Neostigmine and glycopyrrolate were given (2.5 mg/ 0.4 mg) due to the possibility of minor residual neuromuscular blockade. Bispectral index monitoring was applied prior to emergence which eventually reached 100 without any sign of patient movement. Nevertheless, it was apparent that the patient was fully conscious. At this point, he had minimal respiratory effort and cogwheel rigidity, but was able to communicate with us to a limited degree by squeezing our hands. Our opinion was that patient would be unable to swallow his tablets if extubated (placing him at risk of aspiration) and the patient indicated he agreed by squeezing our hand. The patient was then informed of the plan to deepen anaesthesia prior to insertion of a nasogastric tube and administration of his crushed medications.
There was a 15 minute waiting period after initial drug administration of Sinemet and amantadine 100 mg prior to attempting a second wake-up. However, cogwheel rigidity remained minimally improved and respiration was irregular. The patient indicated that he was not confident that he would be able to swallow his tablets if extubated, by squeezing our hand twice. A second cycle was thus conducted with another Sinemet tablet being administered via nasogastric tube, as this was now due. After a further 15 minute waiting period he improved significantly. He was now able to open his eyes and had resumed regular, spontaneous breathing and swallowing. The patient was successfully extubated and after a prolonged observation period in our recovery room, he was returned to the surgical ward.
On day one he was reviewed and the differences between perioperative rigidity and intraoperative awareness were discussed. The patient admitted to downplaying his Parkinson's symptoms preoperatively and was grateful for the care and reassurance he received during emergence from anaesthesia. He was advised to inform his anaesthetists of this episode in the event he required anaesthesia in future.
DISCUSSION
The principal observation of this case was that the patient was found to be profoundly rigid on emergence from prolonged anaesthesia and responded rapidly to two cycles of treatment with Sinemet and one dose of amantadine administered via a nasogastric tube. This rapid response to treatment in this scenario has not been previously documented.
Sinemet (levodopa/carbidopa) is a first-line treatment for Parkinson's disease. Levodopa is converted to dopamine, restoring dopaminergic transmission in the basal ganglia, while carbidopa is a dopa-decarboxylase inhibitor preventing conversion of levodopa in the periphery, thus minimising unwanted peripheral dopaminergic side-effects 2 . It has a short half-life of one to three hours and is absorbed in the proximal small bowel with an onset of action of 15 to 30 minutes 1,2 . Amantadine is a second-line agent which is believed to increase the bioavailability of dopamine within the central nervous system. However, consensus on the precise mechanism of action is lacking 1, 3 . It has a half-life of 16 hours and onset of action of 60 to 90 minutes 1 .
An Ovid-Medline search from 1950 to April 2011 (limited to English) and Google scholar search revealed four case reports in which intraoperative nasogastric Sinemet was used [4] [5] [6] [7] [8] and one case series of three patients from Japan where intravenous levodopa was used to prevent perioperative rigidity 5 . Two case reports focused on elective general surgical patients who were not rigid preoperatively 6, 7 . Furuya et al administered nasogastric Sinemet (100 mg/10 mg) to a 70-year-old man with a 10 year history of Parkinson's disease undergoing elective hepatic lobectomy via the nasogastric route under general anaesthesia 6 . Plasma levodopa concentration measured by chromatography was above the stated minimum therapeutic level of 0.3 µg/ml, demonstrating that plasma levels can be maintained via the nasogastric route in elective surgery.
In the emergency setting, nasogastric Sinemet has been administered in two cases of suspected bowel perforation 4, 8 . Goyal et al administered Sinemet via nasogastric tube every two hours in a 74-year-old man with suspected ileal perforation who awoke smoothly 4 . Kohli et al successfully resuscitated a 74-year-old man preoperatively who presented for laparotomy with decompensated Parkinson's symptoms 8 . His rigidity was successfully reversed prior to anaesthesia with nasogastric Sinemet, which was continued two hourly through the perioperative period. These cases provide limited evidence that nasogastric Sinemet can be given in emergency gastrointestinal surgery despite small bowel pathology and ileus.
There are limited options for parenteral administration of anti-Parkinson's medication in the perioperative period. Fugii cases from Japan where intravenous levodopa was successfully utilised throughout the perioperative period to prevent Parkinsonism in high-risk patients 5 . However, this route of administration is not readily available in Australia. Apomorphine, a short-acting dopamine agonist, can be administered subcutaneously as a bolus or infusion, intranasally or sublingually. However it is highly emetogenic and similarly is not widely available 9 . Anticholinergics such as benzhexol can be administered intravenously and have been used to treat Parkinson's disease 10 . Although these may be more readily available, use of these agents in the perioperative setting for this purpose is not well documented and they may cause postoperative confusion and autonomic side-effects.
A potential criticism of our management is that a nasogastric tube was not inserted at the beginning of the case, which prevented us from giving medication earlier. However, surgery was expected to take less than two hours, in which case the patient would have been able to take his next scheduled dose orally on the ward. Second, there was limited access to the pharynx with the patient's head firmly secured in the beach-chair position, preventing a nasogastric tube from being inserted intraoperatively without significant disruption to the surgery and further time delays. We recommend the insertion of an oro-or nasogastric tube after induction in patients who describe exacerbations with isolated missed doses during their preoperative assessment and whenever there is the potential for missed doses intraoperatively, particularly in those with severe Parkinson's disease. It is also prudent to recognise that awakening from anaesthesia with rigidity can be extremely distressing and communication and reassurance is important while instituting management, such as inserting a nasogastric tube.
In conclusion, we document the rapid and successful reversal of Parkinson's rigidity during emergence from anaesthesia using Sinemet and amantadine via a nasogastric tube and remind readers of the importance of ensuring that doses are not missed perioperatively. We recommend that a naso-or orogastric tube be placed early during cases where there is the potential for prolonged surgery in patients with moderate to severe Parkinson's disease or those who describe rigidity with missed doses.
